|
[1]
|
Luo PF, Yu H, Han RQ, Zhou JY, Wu M. Mortality and years of life lost caused by major kidney diseases in Jiangsu province, 2010-2018. Dis Surveill 2020;35(6):489 − 94. https://doi.org/10.3784/j.issn.1003-9961.2020.06.008CrossRef
|
|
[2]
|
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020;395(10225):709 − 33. https://doi.org/10.1016/S0140-6736(20)30045-3CrossRef
|
|
[3]
|
IHME. Global burden of disease study 2019 (GBD2019) data resources. https://vizhub.healthdata.org/gbd-results/.[2024-3-23]. |
|
[4]
|
Li Y, Ning YC, Shen B, Shi YQ, Song NN, Fang Y, et al. Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019. Clin Kidney J 2023;16(2):312 − 21. https://doi.org/10.1093/ckj/sfac218CrossRef
|
|
[5]
|
Safiri S, Kolahi AA, Mansournia MA, Almasi-Hashiani A, Ashrafi-Asgarabad A, Sullman MJM, et al. The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990-2017. Sci Rep 2020;10(1):13862. https://doi.org/10.1038/s41598-020-70840-2CrossRef
|
|
[6]
|
Safiri S, Hassanzadeh K, Ghaffari Jolfayi A, Mousavi SE, Motlagh Asghari K, Nejadghaderi SA, et al. Kidney cancer in the Middle East and North Africa region: a 30-year analysis (1990-2019). Sci Rep 2024;14(1):13710. https://doi.org/10.1038/s41598-024-64521-7CrossRef
|
|
[7]
|
Wang HX, Fan WL, Yang XY, Chen DY, Huang Q, Pan SY, et al. Trend analysis and forecast of kidney cancer burden in five Asian countries and regions. South China J Prev Med 2023;49(1):1 − 4,9. https://doi.org/10.12183/j.scjpm.2023.0001CrossRef
|
|
[8]
|
Zi H, He SH, Leng XY, Xu XF, Huang Q, Weng H, et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors,1990-2019. Mil Med Res 2021;8(1):60. https://doi.org/10.1186/s40779-021-00354-zCrossRef
|
|
[9]
|
Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010;7(5):245 − 57. https://doi.org/10.1038/nrurol.2010.46CrossRef
|
|
[10]
|
Qin JM. Epidemic trends, problems and countermeasures of chronic diseases and related risk factors in China. Chin J Public Health 2014;30(1):1-4. http://dx.doi.org/10.11847/zgggws2014-30-01-01. (In Chinese) |
|
[11]
|
Ammirati AL. Chronic kidney disease. Rev Assoc Med Bras (1992) 2020;66Suppl 1(Suppl 1):s03-9. http://dx.doi.org/10.1590/1806-9282.66.S1.3. |
|
[12]
|
Mokdad AH, Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C, Shirude S, et al. Trends and patterns of disparities in diabetes and chronic kidney disease mortality among US counties, 1980-2014. Popul Health Metr 2022;20(1):9. https://doi.org/10.1186/s12963-022-00285-4CrossRef
|
|
[13]
|
Wang FL, Yang C, Li PF, Wen FY, Zhang LX. Individual factors contributing to the intercity patient mobility for chronic kidney diseases in China. Chin J Blood Purif 2023;22(5):330 − 4. https://doi.org/10.3969/j.issn.1671-4091.2023.05.003CrossRef
|